National Health (Pharmaceutical Benefits Scheme-Exempt items Section 84AH) Amendment Determination 2018 (No. 2) (PB 61 of 2018) (Cth)

PB 61 of 2018

National Health (Pharmaceutical Benefits Scheme- Exempt items - Section 84AH) Amendment Determination 2018 (No. 2)

National Health Act1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 84AH of the National Health Act 1953.

Dated      27  June 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

1              Name of Instrument

(1)This instrument is the National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination 2018 (No. 2).

(2)This instrument may also be cited as PB 61 of 2018.

2              Commencement

This instrument commences on 1 July 2018.

3              Amendments to PB 81 of 2017

Schedule 1 amends the legislative instrument titled National Health (Pharmaceutical Benefits Scheme – Exempt items – Section 84AH) Determination 2017 (PB 81 of 2017) (as amended)

Schedule 1                   Amendments

[1]  Schedule 1, after entry for Amisulpride, Oral solution 100 mg per mL, 60 mL

Omit:

Amoxycillin Powder for paediatric drops 100 mg (as trihydrate) per mL, 20 mL Oral

Insert:

Amoxicillin Powder for paediatric drops 100 mg (as trihydrate) per mL, 20 mL Oral

[2]  Schedule 1, after entry for Carbamazepine, Oral suspension 100 mg per 5 mL, 300 mL

Insert:

Ciclosporin	Oral liquid 100 mg per mL, 50 mL	Oral
Ciclosporin	Capsule 10 mg	Oral
Ciclosporin	Solution concentrate for I.V. infusion 50 mg in 1 mL	Injection

[3]  Schedule 1, after entry for Clozapine, Oral liquid 50 mg per mL, 100 mL

Omit:

Cyclosporin	Oral liquid 100 mg per mL, 50 mL	Oral
Cyclosporin	Capsule 10 mg	Oral
Cyclosporin	Solution concentrate for I.V. infusion 50 mg in 1 mL	Injection

[4]  Schedule 1, after entry for Fluconazole, Powder for oral suspension 50 mg in 5 mL, 35 mL

Omit:

Frusemide Oral solution 10 mg per mL, 30 mL Oral

Insert:

Furosemide Oral solution 10 mg per mL, 30 mL Oral

[5]  Schedule 1, after entry for Hydromorphone, Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 473 mL

Omit:

Indomethacin Suppository 100 mg Rectal

Insert:

Indometacin Suppository 100 mg Rectal

[6]  Schedule 1, after entry for Paracetamol, Suppositories 500 mg, 24

Omit:

Prochlorperazine Injection containing prochlorperazine mesylate 12.5 mg in 1 mL Injection

Insert:

Prochlorperazine Injection containing prochlorperazine mesilate 12.5 mg in 1 mL Injection